Semaglutide for Smoking Cessation in Patients With Diabetes
Semaglutide for Smoking Cessation in Patients With Diabetes
Recruiting · NCT07059377 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide for Smoking Cessation in Patients With Diabetes | Chemically-Induced Disorders, Nutritional and Metabolic Diseases, Tobacco Dependence, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nicotine dependence, psychiatric disorder, substance-related disorder, type 2 diabetes mellitus | Recruiting | Phase 3 | 2026-09-08 | NCT07059377 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ottawa Heart Institute Research Corporation | 64 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Ottawa Heart Institute | Ottawa | Canada | 61 |